The AI Edge in Biopharma: Greg Meyers on How BMS Applies AI for Smarter Drug Discovery
About this episode
Greg Meyers discusses the application of AI in drug discovery at BMS.
From coder to C-suite, Greg understands the pace of technological change, prioritizes highest value over lowest cost, and stays close to innovation. At BMS, he’s advancing both in-house AI applications and AI-powered R&D—unlocking hidden data patterns that can turn serendipity into systematic discovery.
People in this episode
Guest: Greg Meyers
Topics covered
- AI in biopharma
- drug discovery
- innovation
- R&D
- data patterns
Keywords
- AI
- biopharma
- drug discovery
- R&D
- innovation
- data patterns
Mentioned in this episode
Organizations: BMS
More episodes of The Future of Healthcare AI
- Spanning Every Surface: Google Cloud’s Aashima Gupta on AI, Access, and Adaptive Healthcare
- Medicare meets AI: Andrew Toy on How Clover Health Superpowers Clinicians and Enables Earlier Intervention
- At the Intersection: Jacob and Eli Berlin on How Terray Merges Chemistry and Compute to Drive Drug Discovery
- Where Pharma Wins: Jaswinder Chadha on How Axtria Uses AI to Drive Commercial Ops and Outcomes
- Operationalizing AI: Aman Wasan on How the ArisGlobal Digital Platform Powers Safer, Smarter Therapies
- How AI Turns Data into Discovery
Explore listener stats, chart rankings, contacts and more on the The Future of Healthcare AI podcast page.